Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caracciolo

Showing results (951-960 of 982) with videos related to

Pageof 99
Sort By:
Journal for Immunotherapy of Cancer|June 20, 2020
Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockadePierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli, et al.
Neurology|December 19, 2024
Early vs Late Anticoagulation After Ischemic Stroke in Patients With Atrial Fibrillation and Covert Brain InfarctsMarkus Kneihsl, Arsany Hakim, Martina B Goeldlin, et al.
Journal of Stroke|June 4, 2026
Outcomes of Early Versus Later Anticoagulation in Asian Atrial Fibrillation-Related Stroke: ELAN Subgroup AnalysisTakeshi Yoshimoto, Masafumi Ihara, P N Sylaja, et al.
Journal of Genomics|March 10, 2016
Draft Genome Sequences of Two Pathogenic Corynebacterial Species Isolated from CowsLuis Carlos Guimarães, Thiago Lopes, Rommel Thiago Jucá Ramos, et al.
Haematologica|June 3, 2017
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemiaGabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, et al.
Neuroscience Letters|November 3, 2004
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis?Michelangelo Mancuso, Francesca Luisa Conforti, Anna Rocchi, et al.
Journal of Hematology & Oncology|June 26, 2023
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation studyPierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio, et al.
European Stroke Journal|January 30, 2026
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
European Stroke Journal|August 11, 2025
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
Nature Communications|October 22, 2024
Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene deliverySerena Renzi, Luca Digiacomo, Daniela Pozzi, et al.
Pageof 99

Showing results (951-960 of 982) with videos related to

Sort By:
Pageof 99
Journal for Immunotherapy of Cancer|June 20, 2020
Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockadePierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli, et al.
Neurology|December 19, 2024
Early vs Late Anticoagulation After Ischemic Stroke in Patients With Atrial Fibrillation and Covert Brain InfarctsMarkus Kneihsl, Arsany Hakim, Martina B Goeldlin, et al.
Journal of Stroke|June 4, 2026
Outcomes of Early Versus Later Anticoagulation in Asian Atrial Fibrillation-Related Stroke: ELAN Subgroup AnalysisTakeshi Yoshimoto, Masafumi Ihara, P N Sylaja, et al.
Journal of Genomics|March 10, 2016
Draft Genome Sequences of Two Pathogenic Corynebacterial Species Isolated from CowsLuis Carlos Guimarães, Thiago Lopes, Rommel Thiago Jucá Ramos, et al.
Haematologica|June 3, 2017
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemiaGabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, et al.
Neuroscience Letters|November 3, 2004
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis?Michelangelo Mancuso, Francesca Luisa Conforti, Anna Rocchi, et al.
Journal of Hematology & Oncology|June 26, 2023
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation studyPierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio, et al.
European Stroke Journal|January 30, 2026
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
European Stroke Journal|August 11, 2025
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
Nature Communications|October 22, 2024
Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene deliverySerena Renzi, Luca Digiacomo, Daniela Pozzi, et al.
Pageof 99